SiRNA drug development frames a corporate press release about a biotech collaboration and its strategic plans to advance novel therapeutics.
Key Takeaways
- Partnership achieved its first candidate drug nomination milestone
- IND-enabling studies will start immediately to support planned clinical studies
- Collaboration spans multiple preclinical liver-directed assets targeting MASH